 |
|
| Blog results | Results 1 - 10 of about 1,174 for taxotere and 5 fu. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 11 Nov 2009 The primary objective of the study was to compare the recurrence-free survival of patients receiving single-agent docetaxel (T), followed by cyclophosphamide, epirubicin and 5-FU (CEF) to those receiving docetaxel with capecitabine (XT) ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 12 Jul 2006 In a study of comparing docetaxel plus cisplatin and 5-fluorouracil vs cisplatin plus 5-fluorouracil alone, neutropenia occurred in 96.8% and 93.3% of patients, respectively. Severe (grade 3/4) neutropenia, febrile neutropenia, ... Medscape Hematology-Oncology Headlines - http://www.medscape.com/hematology-oncology [ More results from Medscape Hematology-Oncology Headlines ] |
| 5 Nov 2009 by Skiffin16 Nine weeks of Chemo (Cisplaten, Taxotere and 5FU) followed up with seven weeks of concurrent Carboplaten once a week and 35x Radiation exposures preceded each day with Amifostine injections.... All is clear, no signs of cancer. ... CapMel.com Fishing Forums - http://forums.capmel.com/ |
| 15 Nov 2009 by The Ghost of Snotboogie The two principal studies looking at induction chemotherapy added taxotere to a cisplatin and 5-FU regimen. Vermorken's EORTC trial compared cisplatin 5-FU induction to taxotere, cisplatin and 5-FU for three cycles. ... Snotboogie's Rad Onc Notes - http://theghostofsnotboogie.blogspot.com/ |
| 17 Oct 2009 At a minimum 5 years' follow-up in 88% of the 501 participants in the phase III TAX 324 trial, 52% of those treated with the combined regimen of docetaxel (Taxotere), cisplatin, and 5-FU (the TPF regimen) were alive vs. ... OncologySTAT News - http://www.oncologystat.com/ |
| 17 Sep 2009 by Steve Johnston I did 6 weeks of radiation again, along with 3 cycles of a 'triple chemo' they call TPF- three different chemo drugs at the same time: Cisplatin, Taxotere, and 5-FU. Following this chemotherapy I did a 10-week course of just one newer ... Steve Johnston's Cancer Journey - http://stevescancerjourney.blogspot.com/ - References [ More results from Steve Johnston's Cancer Journey ] |
| 5 Nov 2009 The study involved 1010 women with axillary node–positive or high-risk node-negative breast cancer, randomised to receive 3 cycles of docetaxel or vinorelbine, followed in both groups by 3 cycles of fluorouracil, epirubicin, and cyclophosphamide (FEC). Women with HER2-positive ... The median left ventricular ejection fraction of trastuzumab-treated patients remained unaltered during the 5-year follow-up; one woman treated with trastuzumab was diagnosed with heart failure. ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ [ More results from NeLM - News ] |
| 17 Sep 2009 Since the cotreatment of docetaxel and 5-fluorouracil decreases the activity and expression of thymidylate synthase and dihydropyrimidine dehydrogenase (5-fluorouracil degradation enzyme), and increases the expression of orotate ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 29 Oct 2009 by Prne [1] The multicenter phase III study compared the use of 5-fluorouracil (5FU) alone to 5FU plus 90Y resin microspheres (SIR-Spheres; Sirtex Medical, Sydney) and was conducted by a collaboration of university hospitals in Belgium. ... PR Hub - http://blog.taragana.com/pr/ [ More results from PR Hub ] |
| 1 Oct 2007 by bmirtsching On September 28, 2007, the U. S. Food and Drug Administration (FDA) approved docetaxel (Taxotere® Injection Concentrate, Sanofi-Aventis) for use in combination with cisplatin and fluorouracil (5-FU) for the induction treatment of ... Center for Oncology Research & Treatment--Dalla... - http://cancernews.wordpress.com/ [ More results from Center for Oncology Research & Treatment--Dalla... ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
